DILATED CARDIOMYOPATHY (DCM)

Clinical trials for DILATED CARDIOMYOPATHY (DCM) explained in plain language.

Never miss a new study

Get alerted when new DILATED CARDIOMYOPATHY (DCM) trials appear

Sign up with your email to follow new studies for DILATED CARDIOMYOPATHY (DCM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 5 Not yet finished but already full! 1 Completed 1

Experimental cell therapy targets scar tissue in failing hearts

Disease control Completed

This early-phase study tested a new treatment called CAR-DC in 8 adults with end-stage dilated cardiomyopathy, a condition where the heart becomes enlarged and weak. The therapy uses specially engineered immune cells to target a protein (FAP) linked to scar tissue in the heart. T…

Matched conditions: DILATED CARDIOMYOPATHY (DCM)

Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated May 17, 2026 02:44 UTC

DILATED CARDIOMYOPATHY (DCM)

Get alerted when new DILATED CARDIOMYOPATHY (DCM) trials appear

Experimental cell therapy targets scar tissue in failing hearts